Neurosearch is emptying out the cash register
Neurosearch emerged from the first quarter of 2012 with an operational deficit of DKK 22 million. The company expects to find a solution to its capital issues within a “short term”.
af KRESTEN MORTEN MUNKSGAARD
The biotech company Neurosearch emerged from the first quarter of 2012 with an operational deficit of DKK 22 million and a net deficit of 27.1 million, according to the company’s Q1 report for 2012. It means that the company’s deficit is smaller than in the same period last year, when operations were in the red by DKK 36.6 million and net deficit was a staggering 92.7 million.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Neurosearch: We are keeping our options open
For abonnenter
